Showing results (631-640 of 1,087) with videos related to
Sort By:
Pageof 109
Revista Espanola De Cardiologia (English Ed.)|December 15, 2015
Factors Associated With Delays in Seeking Medical Attention in Patients With ST-segment Elevation Acute Coronary SyndromeFernando Rivero, Teresa Bastante, Javier Cuesta, et al.Journal of the American Heart Association|October 29, 2024
Immediate Versus Staged Complete Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: A Network Meta-Analysis of Randomized TrialsAyman Elbadawi, Mohamed Hamed, Mohamed Gad, et al.Advanced Healthcare Materials|January 25, 2020
Plasmonic Copper Sulfide Nanoparticles Enable Dark Contrast in Optical Coherence TomographyRiccardo Marin, José Lifante, Lucas V Besteiro, et al.Cardiovascular Diagnosis and Therapy|March 21, 2025
Ultrasound imaging of congestion in heart failure: a narrative reviewÁlvaro Gamarra, Jorge Salamanca, Pablo Díez-Villanueva, et al.European Heart Journal|January 30, 2020
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromesRobert F Storey, Paul A Gurbel, Jurrien Ten Berg, et al.Circulation. Cardiovascular Interventions|June 1, 2012
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trialRobert C Welsh, Sunil V Rao, Uwe Zeymer, et al.The Heart Surgery Forum|April 30, 2013
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgeryMichael S Firstenberg, Cornelius M Dyke, Dominick J Angiolillo, et al.NEJM Evidence|February 6, 2024
Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent SurgeryDeepak L Bhatt, Charles V Pollack, C David Mazer, et al.Thrombosis and Haemostasis|November 27, 2015
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient dataJean-Luc Reny, Pierre Fontana, Willibald Hochholzer, et al.European Heart Journal. Acute Cardiovascular Care|January 3, 2024
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelinesAntonio Landi, Victor Aboyans, Dominick J Angiolillo, et al.Pageof 109